Crestar Labs Funding: How Much Did They Raise & Key Investors

How Much Did Crestar Labs Raise?
Funding & Key Investors

Crestar Labs has successfully secured a significant capital injection, bringing its total cumulative financing to $675K. This latest infusion of capital, represented by a $325K strategic investment, underscores the firm's robust position within the high-complexity clinical diagnostics sector. By leveraging this recent backing, the organization is poised to accelerate its operational footprint and enhance its diagnostic capabilities, ensuring that its specialized toxicology and genetic analysis services remain at the forefront of the healthcare industry.

The company's growth trajectory, marked by consistent debt-based financing rounds, reflects a disciplined approach to scaling its infrastructure. As the demand for rapid, accurate, and reliable laboratory results continues to climb, Crestar Labs remains committed to maintaining its rigorous validation standards and rapid turnaround times, which are essential for modern clinical decision-making.

What is Crestar Labs?

Crestar Labs

Healthcare Services

Medical Laboratories & Imaging Centers

Crestar Labs operates as an accredited, high-complexity clinical reference laboratory specializing in esoteric toxicology and genetic analysis. The firm serves a diverse clientele, including physician offices, substance abuse clinics, mental health facilities, and rehabilitation programs. By providing actionable diagnostic data, the company empowers healthcare providers to improve patient outcomes while simultaneously driving cost efficiencies. The organization distinguishes itself through a commitment to quality, offering expert consultation and comprehensive report interpretation within a 48-hour window, thereby positioning itself as a critical partner in the continuum of patient care.

How much funding has Crestar Labs raised?

Crestar Labs has raised a total of $675K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$325K

Debt (2020): $350K with participation from PPP

Debt (2021): $325K led by PPP

Key Investors in Crestar Labs

PPP

Public-Private Partnership

What's next for Crestar Labs?

With the recent influx of capital, Crestar Labs is strategically positioned to scale its laboratory operations and further refine its diagnostic testing suite. The company's forward-looking strategy involves deepening its investment in advanced genetic analysis technologies and expanding its reach within the mental health and substance abuse treatment markets. By prioritizing technological integration and maintaining its high-standard validation protocols, Crestar Labs aims to solidify its market share and continue providing the essential diagnostic tools that clinicians rely on for effective patient management. The focus remains on operational excellence and the continued expansion of its service portfolio to meet the evolving needs of the healthcare landscape.

See full Crestar Labs company page

See More Financial Insights